Health
Novel antiviral drug candidate blocks SARS-CoV-2 reproduction in cells – Drug Target Review
In human cell assays, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.
Posted: 16 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
In human cells, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.
A study in human cells found that an antiviral drug candidate called PF-00835231 may be at least as potent as the drug remdesivir at blocking the reproduction of SARS-CoV-2, which causes COVID-19.
PF-00835231 was shown in preliminary research in cells – conducted by New York University Grossman…
-
Noosa News17 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General18 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General15 hours agoIncreased police powers begin at Adelaide Oval Ashes Test following Bondi attacks
-
General23 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says